Pharmaceutical and medicine manufacturing

NAICS Code: 325400

Employment 2024
350,500
Projected 2034
369,500
Growth Rate
+5.4%
Net Job Change
+19,000
The verdict

BLS projects Pharmaceutical and medicine manufacturing to grow +5.4% through 2034 - 3.0 points faster than the 2.4% average across 291 U.S. industries, faster-growing than 76% of them. Its trajectory is close to the typical U.S. industry.

+5.4%
Growth 2024-34
76th
growth percentile
350,500
Workers (2024, ×1k)
+19,000
Net jobs (×1k)

Where Pharmaceutical and medicine manufacturing sits among all industries

Projected 2024-2034 growth across 291 U.S. industries (BLS). This industry is marked in rose.

Where Pharmaceutical and medicine manufacturing sits by projected growth

Projected employment change across tracked industries

5.4% Top 24% higher than 76% of 291 industries

Industries, banded by projected growth

Each bar is a band; taller bars hold more industries. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source BLS Employment Projections · 2026-05-15

Expansion read

Signature: 36.9% mean employer AI exposure across 97 tracked public companies .

BLS projects above-average headcount growth here, and the SEC employer cohort for this NAICS sector is one of the denser slices we track - use the company grades below as a staffing-pattern check, not a firm-level forecast.

NAICS 325400 · 350,500 workers (2024, ×1k) · source BLS Employment Projections 2024-2034. Employer AI grades are occupation-weighted scores from our SEC cohort, not automation predictions for every establishment in Pharmaceutical and medicine manufacturing.

Public companies near this industry

SEC industry labels matching tokens from Pharmaceutical and medicine manufacturing. 97 companies scored · mean AI exposure 36.9%.

B · 97
Tracked public companies tied to this industry sector with AI risk grades
Company AI grade
Abbott Laboratories B
AbbVie Inc. B
Abivax S.A. B
Acadia Pharmaceuticals Inc B
Alkermes plc. B
Alnylam Pharmaceuticals, Inc. B
Alumis Inc. B
Amicus Therapeutics, Inc. B

Grades are occupation-weighted AI exposure from our employer corpus - not a claim that every establishment in Pharmaceutical and medicine manufacturing shares the same risk. Source: SEC company metadata + O*NET-weighted scores · as of 2026-05-15.

Peer Industries by Employment

How Pharmaceutical and medicine manufacturing (NAICS 325400) compares to industries of similar size, ordered by 2024 BLS employment.

Peer industries by 2024 employment, with 2034 projections and growth rates
Industry 2024 Growth
Civic and social organizations 364,400 +3.1%
Rental and leasing services (5322,3,4) 362,300 +1.0%
Other nondepository credit intermediation 358,400 -0.7%
Printing and related support activities 357,200 -15.5%
Pharmaceutical and medicine manufacturing 350,500 +5.4%
Bakeries and tortilla manufacturing 350,400 +5.4%

Peers are selected by similarity in 2024 employment. Figures in thousands. Source: BLS Employment Projections 2024-2034.

Frequently Asked Questions

How many people work in Pharmaceutical and medicine manufacturing?

As of 2024, the Pharmaceutical and medicine manufacturing industry employs approximately 350,500 workers in the United States, according to BLS Employment Projections data.

Is Pharmaceutical and medicine manufacturing growing or declining?

The Pharmaceutical and medicine manufacturing industry is projected to grow by 5.4% from 2024 to 2034, a net change of +19,000 jobs over the decade.

Which public companies sit near Pharmaceutical and medicine manufacturing?

97 tracked public companies whose SEC industry label matches Pharmaceutical and medicine manufacturing. Sample names include Abbott Laboratories, AbbVie Inc., Abivax S.A.. Grades are occupation-weighted AI exposure scores, not company-specific automation forecasts.

How will AI affect the Pharmaceutical and medicine manufacturing industry?

Among 97 tracked public companies tied to this industry's sector, the mean occupation-weighted AI exposure score is 36.9% (most common grade B). That is a staffing-pattern signal from our employer corpus, not a forecast for every firm in Pharmaceutical and medicine manufacturing. Pair it with occupation-level AI exposure scores for role-specific risk.

What to do with this

Use Pharmaceutical and medicine manufacturing's employment and exposure numbers above to look up individual employers and occupations, not just the industry aggregate.

Industry-level figures are aggregates; individual employer and occupation outcomes vary.

Source: Bureau of Labor Statistics Employment Projections 2024-2034; SEC employer metadata for AI grades Employment figures in thousands. Employer grades are occupation-weighted exposure scores, not firm automation forecasts